Thermo Fisher Scientific Inc.
TMO · NYSE
9/27/2025 | 6/28/2025 | 3/29/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,982,000 | $4,579,000 | $4,134,000 | $4,009,000 |
| Short-Term Investments | $1,564,000 | $1,814,000 | $1,813,000 | $1,561,000 |
| Receivables | $8,911,000 | $10,035,000 | $9,821,000 | $9,626,000 |
| Inventory | $5,745,000 | $5,559,000 | $5,224,000 | $4,978,000 |
| Other Curr. Assets | $4,093,000 | $2,597,000 | $2,386,000 | $1,963,000 |
| Total Curr. Assets | $22,295,000 | $24,584,000 | $23,378,000 | $22,137,000 |
| Property Plant & Equip (Net) | $10,177,000 | $9,635,000 | $9,331,000 | $10,795,000 |
| Goodwill | $49,287,000 | $47,249,000 | $46,493,000 | $45,853,000 |
| Intangibles | $16,242,000 | $15,148,000 | $15,323,000 | $15,533,000 |
| Long-Term Investments | $0 | $198,000 | $374,000 | $560,000 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5,019,000 | $4,416,000 | $4,142,000 | $2,443,000 |
| Total NC Assets | $80,725,000 | $76,646,000 | $75,663,000 | $75,184,000 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $103,020,000 | $101,230,000 | $99,041,000 | $97,321,000 |
| Liabilities | – | – | – | – |
| Payables | $2,980,000 | $2,980,000 | $3,049,000 | $3,079,000 |
| Short-Term Debt | $3,823,000 | $2,214,000 | $2,819,000 | $2,475,000 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2,852,000 | $2,805,000 | $2,866,000 | $2,852,000 |
| Other Curr. Liab. | $3,245,000 | $1,000 | $3,021,000 | $2,938,000 |
| Total Curr. Liab. | $14,888,000 | $12,718,000 | $13,174,000 | $13,332,000 |
| LT Debt | $31,857,000 | $33,015,000 | $31,370,000 | $29,061,000 |
| Deferred Rev, NC | $1,122,000 | $1,122,000 | $1,127,000 | $1,138,000 |
| Deferred Tax Liab, NC | $1,041,000 | $624,000 | $1,041,000 | $1,268,000 |
| Other NC Liab. | $3,088,000 | $3,148,000 | $2,844,000 | $1,612,000 |
| Total NC Liab. | $37,108,000 | $37,910,000 | $36,382,000 | $34,318,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $31,857,000 | $33,015,000 | $31,370,000 | $29,061,000 |
| Total Liabilities | $51,996,000 | $50,628,000 | $49,555,000 | $47,650,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $444,000 | $444,000 | $444,000 | $444,000 |
| Retained Earnings | $55,901,000 | $55,901,000 | $54,447,000 | $53,102,000 |
| AOCI | -$2,797,000 | -$2,797,000 | -$2,342,000 | -$2,697,000 |
| Other Equity | $0 | $0 | -$1,000 | -$1,000 |
| Total Equity | $51,024,000 | $50,511,000 | $49,390,000 | $49,584,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $129,000 | $91,000 | $95,000 | $87,000 |
| Total Liab. & Tot. Equity | $103,020,000 | $101,230,000 | $99,041,000 | $97,321,000 |
| Net Debt | $33,698,000 | $30,650,000 | $30,055,000 | $27,527,000 |